ALLK News

SAN FRANCISCO, May 09, 2020 -- Hagens Berman updates investors in the following publicly-traded companies and urges investors who have suffered significant losses to contact.

  • Allakos (NASDAQ:ALLK): Q1 GAAP EPS of -$0.57.
  • Cash, equivalents and marketable securities of $479.8M.

SAN FRANCISCO, CA / ACCESSWIRE / May 10, 2020 / Hagens Berman urges Allakos Inc. ( NASDAQ:ALLK ) investors who have suffered significant losses to submit their losses now . Tomorrow is the lead plaintiff ...

Allakos (ALLK) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

NEW YORK, NY / ACCESSWIRE / May 10, 2020 / Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allakos Inc. (NASDAQ:ALLK) between August 5, 2019 through December ...

Los Angeles, California--(Newsfile Corp. - May 9, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Allakos Inc. ("Allakos" or "the Company") (NASDAQ: ALLK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 5, 2019 and December 17, 2019, ...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allakos Inc. (NASDAQ: ALLK) between August 5, 2019 through December 17, 2019, inclusive (the “Class Period”) of the important May 11, 2020 le…

Los Angeles, California--(Newsfile Corp. - May 10, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Allakos Inc. ("Allakos" or "the Company") (NASDAQ: ALLK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 5, 2019 and December 17, 2019, ...

LOS ANGELES, CA / ACCESSWIRE / May 8, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Allakos Inc. ("Allakos" or "the Company") (NASDAQ:ALLK) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 5, 2019 and December 17, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before May 11, 2020.

Los Angeles, California--(Newsfile Corp. - May 11, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Allakos Inc. (NASDAQ: ALLK) ("Allakos" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 5, 2019 and December 17, 2019, inclusive (the ...

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allakos Inc. (NASDAQ: ALLK) between August 5, 2019 through December 17, 2019, inclusive (the "Class Period") of the important May 11, 2020 lead plaintiff deadline in the securities class action commenced by the firm. The lawsuit seeks to recover damages for Allakos investors under the federal securities laws.

NEW YORK, NY / ACCESSWIRE / May 10, 2020 / Pomerantz LLP is investigating claims on behalf of investors of Allakos Inc. ("Allakos" or the "Company") (NASDAQ:ALLK). Such investors are ...

Safirstein Metcalf LLP announces that a class action has been filed on behalf of investors that purchased the securities of Allakos Inc. (“Allakos” or the “Company”) (ALLK) between August 5, 2019 and December 17, 2019 (the “Class Period”). If you purchased Allakos securities during the Class Period and would like more information about the shareholder class action, please contact Safirstein Metcalf LLP at 1-800-221-0015, or email info@SafirsteinMetcalf.com. If you wish to serve as a lead plaintiff, you must move the Court no later than May 11, 2020.

NEW YORK--(BUSINESS WIRE)--Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquire…

REDWOOD CITY, Calif., May 21, 2020 -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antolimab (AK002) for the treatment of eosinophil and mast.

REDWOOD CITY, Calif., May 11, 2020 -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antolimab (AK002) for the treatment of eosinophil and mast.

Allakos Inc (ALLK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).

REDWOOD CITY, Calif., May 11, 2020 -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antolimab (AK002) for the treatment of eosinophil and mast.

LOS ANGELES, CA / ACCESSWIRE / May 9, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Allakos Inc. ("Allakos" or "the Company") (NASDAQ:ALLK) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 5, 2019 and December 17, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before May 11, 2020.

NEW YORK, NY / ACCESSWIRE / May 11, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Allakos Inc. ("Allakos" or the Company") ...

NEW YORK, NY / ACCESSWIRE / May 8, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Allakos Inc. ("Allakos" or the Company") ...

Homology (FIXX) is a gene therapy company whose technology has been criticized by scientists as “untrue to the scientific community.”.On April 15th, 2020, a key patient in FIXX’s only Phase 1/2 clinical trial shared test results on Facebook that suggest FIXX’…

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Allakos Inc. (“Allakos” or the “Company”) (ALLK) of the May 11, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

LOS ANGELES, CA / ACCESSWIRE / May 10, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Allakos Inc. ("Allakos" or "the Company") (NASDAQ:ALLK) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 5, 2019 and December 17, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before May 11, 2020.

  • Private-equity firms are sitting on an estimated $1.5 trillion in cash that can be used to acquire companies. 
  • The coronavirus crisis has cheapened the valuations of many popular companies and made them potential targets for deals.